Latest News - Chemence Medical, Inc.

Exofin precision pen box and pen device

31

Jan

Chemence Medical Received FDA Approval for exofin Precision Pen

January 31, 2022 Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell the Exofin® Precision Pen as a new medical device for wound closure. The Exofin Precision Pen will enable medical providers greater versatility and exactness in closing wounds while also Chemence Medical Received FDA Approval for exofin Precision Pen

5

May

Chemence Opens New Research and Development Facility

Chemence Center of Excellence to focus on adhesive technology innovation Alpharetta, GA — Chemence, a global company with specialized expertise in the field of polymerizable technology, announced the opening of the Chemence Center of Excellence, a state-of-the-art research and development facility in Alpharetta, Georgia. The facility is home to a large team of Chemence’s scientists Chemence Opens New Research and Development Facility

Exofin Fusion Skin Closure System Image of mesh strip and adhesive applicator tube.

9

Apr

Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

Medical technologies manufacturer improves patient care with enhanced skin closure system Alpharetta, GA — Chemence Medical, a world leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion® skin closure system. Exofin fusion combines a self-adhering flexible mesh strip and a fast-curing 2-octyl Chemence Medical Receives FDA Approval for Exofin Fusion® Redesign

25

Feb

Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive

Alpharetta, Georgia – February 15, 2016 Chemence Medical, Inc., a manufacturer and distributor of adhesive-based medical devices, announced it received Food and Drug Administration clearance to market and sell Exofin®, a new topical skin adhesive for wound closure. Exofin enters the market as the fastest polymerizing 2-octyl cyanoacrylate topical adhesive available and as the highest Chemence Medical Receives FDA Clearance for Exofin® Tissue Adhesive